Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


18.03.2019

5 Aliment Pharmacol Ther
2 Clin Gastroenterol Hepatol
1 Dig Dis Sci
1 Dis Colon Rectum
1 Eur J Gastroenterol Hepatol
6 Inflamm Bowel Dis
6 J Crohns Colitis
1 J Pediatr
1 PLoS Biol
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Z Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. WILS P, Bouhnik Y, Michetti P, Flourie B, et al
    Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience.
    Aliment Pharmacol Ther. 2018;47:588-595.
    PubMed     Text format     Abstract available

  2. LIGHTNER AL, McKenna NP, Tse CS, Raffals LE, et al
    Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations.
    Aliment Pharmacol Ther. 2018;47:573-580.
    PubMed     Text format     Abstract available

  3. SINGH S, Andersen NN, Andersson M, Loftus EV Jr, et al
    Comparison of infliximab with adalimumab in 827 biologic-naive patients with Crohn's disease: a population-based Danish cohort study.
    Aliment Pharmacol Ther. 2018;47:596-604.
    PubMed     Text format     Abstract available

  4. JALANKA J, Hillamaa A, Satokari R, Mattila E, et al
    The long-term effects of faecal microbiota transplantation for gastrointestinal symptoms and general health in patients with recurrent Clostridium difficile infection.
    Aliment Pharmacol Ther. 2018;47:371-379.
    PubMed     Text format     Abstract available

  5. DREESEN E, Van Stappen T, Ballet V, Peeters M, et al
    Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response.
    Aliment Pharmacol Ther. 2018;47:346-355.
    PubMed     Text format     Abstract available


    Clin Gastroenterol Hepatol

  6. EGBERG MD, Galanko JA, Kappelman MD
    Patients Who Undergo Colectomy for Pediatric Ulcerative Colitis at Low-volume Hospitals Have More Complications.
    Clin Gastroenterol Hepatol. 2019 Mar 7. pii: S1542-3565(19)30251.
    PubMed     Text format     Abstract available

  7. KHAN N, Lee H, Trivedi C, Kavani H, et al
    Mortality Associated With Development of Squamous Cell Cancer in Patients With Inflammatory Bowel Disease Receiving Treatment With Thiopurines.
    Clin Gastroenterol Hepatol. 2019 Mar 7. pii: S1542-3565(19)30254.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  8. ZHAO S, Wang J, Zhao Z
    Inflammatory Bowel Diseases and Sexual Health: More Studies Are Needed.
    Dig Dis Sci. 2019;64:594-595.
    PubMed     Text format    


    Dis Colon Rectum

  9. AYTAC E, Dietz DW, Ashburn J, Remzi FH, et al
    Is Conversion of a Failed IPAA to a Continent Ileostomy a Risk Factor for Long-term Failure?
    Dis Colon Rectum. 2019;62:217-222.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  10. DAVIS R, McParland P, Dodd S, Storey D, et al
    Comparative effectiveness of antitumour necrosis factor agents and vedolizumab in ulcerative colitis.
    Eur J Gastroenterol Hepatol. 2019 Mar 6. doi: 10.1097/MEG.0000000000001395.
    PubMed     Text format     Abstract available


    Inflamm Bowel Dis

  11. HIRTEN RP, Grinspan A, Fu SC, Luo Y, et al
    Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 10. pii: 5372769. doi: 10.1093.
    PubMed     Text format     Abstract available

  12. FILIPPONE RT, Sahakian L, Apostolopoulos V, Nurgali K, et al
    Eosinophils in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 11. pii: 5374663. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. SHMIDT E, Suarez-Farinas M, Mallette M, Moniz H, et al
    Erectile Dysfunction Is Highly Prevalent in Men With Newly Diagnosed Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 11. pii: 5376643. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. LI Y, Liu X
    Shall Patients With a History of Inflammatory Bowel Disease-Related Surgery Be Excluded in the Assessment of Sexual Function?
    Inflamm Bowel Dis. 2019 Mar 15. pii: 5381151. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. BUCHNER AM
    Confocal Laser Endomicroscopy in the Evaluation of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 16. pii: 5382084. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. LIMDI JK, Farraye J, Cannon R, Woodhams E, et al
    Contraception, Venous Thromboembolism, and Inflammatory Bowel Disease: What Clinicians (and Patients) Should Know.
    Inflamm Bowel Dis. 2019 Mar 16. pii: 5382083. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Crohns Colitis

  17. ALLOCCA M, Fiorino G, Bonifacio C, Furfaro F, et al
    Comparative Accuracy of Bowel Ultrasound Versus Magnetic Resonance Enterography in Combination With Colonoscopy in Assessing Crohn's Disease and Guiding Clinical Decision-making.
    J Crohns Colitis. 2018;12:1280-1287.
    PubMed     Text format     Abstract available

  18. HUTTER S, van Haaften WT, Hunerwadel A, Baebler K, et al
    Intestinal Activation of pH-Sensing Receptor OGR1 [GPR68] Contributes to Fibrogenesis.
    J Crohns Colitis. 2018;12:1348-1358.
    PubMed     Text format     Abstract available

  19. AZIMIRAD M, Yadegar A, Asadzadeh Aghdaei H, Kelly CR, et al
    Enterotoxigenic Clostridium perfringens Infection as an Adverse Event After Faecal Microbiota Transplantation in Two Patients With Ulcerative Colitis and Recurrent Clostridium difficile Infection: A Neglected Agent in Donor Screening.
    J Crohns Colitis. 2019 Mar 10. pii: 5372934. doi: 10.1093.
    PubMed     Text format    

  20. KRUIS W, Nguyen P, Morgenstern J, Ramlow W, et al
    Novel Leucocyte/Thrombocyte Apheresis for Induction of Steroid-Free Remission in Ulcerative Colitis: A Controlled Randomized Pilot Study.
    J Crohns Colitis. 2019 Mar 13. pii: 5376679. doi: 10.1093.
    PubMed     Text format     Abstract available

  21. SOOD A, Mahajan R, Singh A, Midha V, et al
    Role of Fecal Microbiota Transplantation for Maintenance of Remission in Patients with Ulcerative Colitis: A Pilot Study.
    J Crohns Colitis. 2019 Mar 11. pii: 5381070. doi: 10.1093.
    PubMed     Text format     Abstract available

  22. LOO SY, Vutcovici M, Bitton A, Lakatos PL, et al
    Risk of malignant cancers in inflammatory bowel disease.
    J Crohns Colitis. 2019 Mar 15. pii: 5381147. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Pediatr

  23. LEVY R, Amarilyo G, Tal R, Amir J, et al
    Musculoskeletal Manifestations as Presenting Symptoms of Inflammatory Bowel Disease in Children and Adolescents.
    J Pediatr. 2019 Mar 8. pii: S0022-3476(18)31722.
    PubMed     Text format     Abstract available


    PLoS Biol

  24. LYONS J, Ghazi PC, Starchenko A, Tovaglieri A, et al
    The colonic epithelium plays an active role in promoting colitis by shaping the tissue cytokine profile.
    PLoS Biol. 2018;16:e2002417.
    PubMed     Text format     Abstract available


    PLoS One

  25. MATSUOKA K, Hamada S, Shimizu M, Nanki K, et al
    Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn's disease.
    PLoS One. 2018;13:e0204632.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  26. LI Y, Fuhrer M, Bahrami E, Socha P, et al
    Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases.
    Proc Natl Acad Sci U S A. 2019;116:970-975.
    PubMed     Text format     Abstract available


    Z Gastroenterol

  27. ROGGENBROD S, Schuler C, Haller B, Sohn M, et al
    [Patient perception and approval of fecal microbiota transplantation (FMT) as an alternative treatment option for ulcerative colitis].
    Z Gastroenterol. 2019;57:296-303.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: